Who owns Avrobio Ord?
- Ticker: AVRO
- CUSIP Number: 05455m100
Tip: Access positions for across all investors
Analyze quarterly positions in Avrobio Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Avrobio Ord stock
Who bought or sold Avrobio Ord this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Atlas Venture Life Science Advisors | 4.5M | $5.8M | 0% | Mar 2024 |
|
BML Capital Management | 4.0M | $5.1M | 0% | Mar 2024 |
|
ADAR1 Capital Management | 4.0M | $5.1M | 7787% | Mar 2024 |
|
FMR | 2.0M | $25M | 100% | Mar 2024 |
|
Verition Fund Management | 1.9M | $2.5M | 100% | Mar 2024 |
|
Vanguard Group | 1.9M | $2.4M | 17% | Mar 2024 |
|
Acadian Asset Management | 1.2M | $1.6M | -28% | Mar 2024 |
|
Newtyn Management | 1.1M | $1.4M | -59% | Mar 2024 |
|
Aisling Capital Management | 1.0M | $1.4M | 0% | Dec 2023 |
|
Tang Capital Management | 853k | $1.1M | 100% | Mar 2024 |
|
Ikarian Capital | 754k | $965k | 5% | Mar 2024 |
|
BlackRock | 613k | $787k | -1% | Mar 2024 |
|
Prosight Management | 567k | $725k | 100% | Mar 2024 |
|
Aldebaran Capital | 517k | $662k | 10% | Mar 2024 |
|
Citadel Advisors | 446k | $571k | -16% | Mar 2024 |
|
Geode Capital Management | 372k | $477k | 5% | Mar 2024 |
|
Two Sigma Advisers | 296k | $379k | 12% | Mar 2024 |
|
Two Sigma Investments | 271k | $346k | -13% | Mar 2024 |
|
Bridgeway Capital Management | 267k | $342k | 81% | Mar 2024 |
|
Boothbay Fund Management | 191k | $244k | 23% | Mar 2024 |
|
Morgan Stanley | 160k | $204k | -69% | Mar 2024 |
|
Vazirani Asset Management | 150k | $192k | -77% | Mar 2024 |
|
Walleye Trading Advisors | 136k | $174k | 100% | Mar 2024 |
|
Wells Fargo & Company | 126k | $161k | -6% | Mar 2024 |
|
FNY Investment Advisers | 75k | $96k | -81% | Mar 2024 |
|
Northern Trust | 67k | $86k | -9% | Mar 2024 |
|
Exome Asset Management | 61k | $78k | 100% | Mar 2024 |
|
BBR Partners | 60k | $77k | 0% | Mar 2024 |
|
Squarepoint Ops | 39k | $50k | 100% | Mar 2024 |
|
Susquehanna International | 35k | $44k | -73% | Mar 2024 |
|
XTX Topco | 24k | $31k | -16% | Mar 2024 |
|
Barclays | 17k | $22k | 0% | Mar 2024 |
|
Colonial River Wealth Management | 16k | $21k | 0% | Mar 2024 |
|
Two Sigma Securities | 11k | $13k | 100% | Mar 2024 |
|
CWM | 6.4k | $8.0k | 0% | Mar 2024 |
|
Advisor Group Holdings | 4.0k | $5.1k | -50% | Mar 2024 |
|
Tower Research Capital | 3.1k | $4.0k | -40% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 3.0k | $3.8k | 0% | Mar 2024 |
|
Royal Bank of Canada | 1.9k | $0 | 0% | Mar 2024 |
|
Rhumbline Advisers | 1.2k | $1.5k | 0% | Mar 2024 |
|
National Bank Of Canada /fi/ | 380.00 | $542.982000 | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 282.00 | $360.988200 | 0% | Mar 2024 |
|
Group One Trading | 13.00 | $17.000100 | 100% | Mar 2024 |
|
Bank of America Corporation | 2.00 | $2.000000 | -93% | Mar 2024 |
|
Who sold out of Avrobio Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Western Standard | Dec 2023 | 313k | $426k |
JBF Capital | Sep 2023 | 160k | $246k |
Bank of New York Mellon | Dec 2023 | 17k | $23k |
Commonwealth Equity Services | Dec 2023 | 11k | $15k |
Virtu Financial | Dec 2023 | 10k | $14k |
IFP Advisors | Sep 2023 | 3.5k | $5.4k |